HighTower Advisors’s Immunic IMUX Stock Holding History

HighTower Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-25	Closed	-$3K	–	2282
2018 Q3	$3K	Hold	25	–	–	﹤0.01%	2238
2018 Q2	$69K	Hold	25	–	–	﹤0.01%	2041
2018 Q1	$68K	Hold	25	–	–	﹤0.01%	1997
2017 Q4	$60K	Hold	25	–	–	﹤0.01%	2086
2017 Q3	$51K	Hold	25	–	–	﹤0.01%	2082
2017 Q2	$29K	Hold	25	–	–	﹤0.01%	2053
2017 Q1	$40K	Hold	25	–	–	﹤0.01%	1940
2016 Q4	$44K	Hold	25	–	–	﹤0.01%	1826
2016 Q3	$61K	Hold	25	–	–	﹤0.01%	1772
2016 Q2	$62K	Hold	25	–	–	﹤0.01%	1634
2016 Q1	$91K	Hold	25	–	–	﹤0.01%	1920
2015 Q4	$115K	Hold	25	–	–	﹤0.01%	1832
2015 Q3	$40K	Buy	+25	New	+$125K	﹤0.01%	1787

Other funds holding IMUX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

HighTower Advisors's IMUX Position: Q4 2018 in Review

HighTower Advisors sold out of Immunic (IMUX) in Q4 2018, closing a stake of 25 shares — an estimated $3K sold.

HighTower Advisors first reported a position in IMUX in Q3 2015 and held it in 13 quarters. The position peaked at $115K in Q4 2015. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

HighTower Advisors reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
HighTower Advisors sold 25 Immunic shares in Q4 2018, an estimated $3K.
HighTower Advisors first reported a position in Immunic in Q3 2015 and held it in 13 quarters.
HighTower Advisors's Immunic position peaked at $115K in Q4 2015.
47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.